Delivery Order SPE2DR25D3021-SPE2DR26FS8VA
- Not listed
- On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $4,184.82 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG Tablet 8S, a migraine treatment medication. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is January 12, 2026, and performance will take place at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- On January 12, 2026, the Defense Logistics Agency awarded a delivery order valued at $38,284.25 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by January 13, 2026, with performance occurring at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $22,469.61 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 11, 2025, and represents a small-value pharmaceutical delivery. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $3,903.15 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count). This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of December 3, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $18,833.77 for NURTEC ODT 75 mg tablets (8-count units) on November 12, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count). This is a firm fixed price delivery order with a ceiling value of $11,327.55 and an ultimate completion date of November 4, 2025. The award was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $3,107.17 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on June 2, 2025, with an ultimate completion date of June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- The Defense Logistics Agency awarded a $11,724.02 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (quantity: 8 units) on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-set-aside, firm fixed-price delivery order was issued under competitive procedures and represents a pharmaceutical supply transaction for federal medical procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $12,153.68. This is a firm fixed-price delivery order under a non-set-aside competitive procurement, with performance scheduled for completion by November 28, 2025, at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a pharmaceutical supply transaction supporting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $25,323.36 to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the competitive nature of the award....
- SPE2DR25D3021Indefinite Delivery Contract
- SPE2DR25D3021-SPE2DR26FS8VADelivery Order
On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $8,186.80 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets in quantities of 8 units. This is a firm fixed-price, non-competitive award with an ultimate completion date of January 15, 2026. The contract represents a purchase order for pharmaceutical products that will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.9 billion vehicle valued through December 2031. This comprehensive IDC serves as the primary contracting mechanism for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and medical devices. The award demonstrates AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting Defense Health Agency requirements and military treatment facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 1/13/26 |